Childhood acute lymphoblastic leukemia in the Netherlands - Randomized studies and nationwide treatment results from 1972 to 1995

AV Does-Van den Berg, AJP Veerman, ER Van Wering, JA De Vries, FC De Waal, GE Van Zanen, JF Van Weerden, WA Kamps

    OnderzoeksoutputAcademicpeer review

    11 Citaten (Scopus)

    Samenvatting

    The Dutch Childhood Leukemia Study Group (DCLSG) has implemented eight protocols for the treatment of childhood acute lymphoblastic leukemia (ALL) (ALL I to VIII) during the period from 1972 to 1995. They were based on St. Jude's Total Therapy (ALL II to VI) and the risk-adapted intensive therapy (ALL VII and VIII) developed by the BFM Group, respectively, and included seven randomized studies. In study ALT, I (N = 43, 1972 to 1973), no effect was observed after the addition of daunorubicin to vincristine/prednisone pulses during maintenance treatment. In study ALL II (N = 143, 1973 to 1975) the addition of cyclophosphamide to maintenance treatment with 6-mercaptopurine/methotrexate increased toxicity and mortality without increasing the event-free survival rate. In study ALL III (N = 148; 1975 to 1979) for non-high-risk patients (defined as initial leukocyte count

    Originele taal-2English
    Pagina's (van-tot)125-139
    Aantal pagina's15
    TijdschriftInternational journal of pediatric hematology/oncology
    Volume5
    Nummer van het tijdschrift2-4
    StatusPublished - 1998

    Citeer dit